OIF Patient-led Listening Session at the U.S. Food and Drug Administration (FDA)
09/17/2019 Objective of session The objectives of the session were to discuss with the U.S. Food and Drug Administration (FDA)
Brendan Lee
NIH Grant Funds Brittle Bone Disorders Consortium
As the lead patient advocacy organization of the Brittle Bone Disorders Consortium (BBDC), part of the NIH’s Rare Diseases Clinical
OIF Podcast Series
The OI Foundation’s podcast series discusses innovative research studies and educational topics in OI. Click here to view the full